SEC Form 3 · accession 0000939798-17-000101
GT Biopharma, Inc. · GTBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond W. Urbanski
Officer — Chief Medical Officer
Period of report
Sep 1, 2017
Accepted (ET)
Dec 1, 2017 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000109657
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | holding | — | — | — | 1,528,989 | D |
Table II — derivative securities
No Table II lines on this filing.